Find Your Next Blockbuster with DrugPatentWatch -- accurate, actionable, and timely intelligence

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Boehringer Ingelheim

Moodys

Harvard Business School

Express Scripts

Medtronic

4.3/5 based on G2 reviews

4.4/5 based on Crozdesk reviews

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Life is better with DrugPatentWatch.

Reliable primary data + expert analysis. We provide answers for your burning questions.

→ See why others have switched

DrugPatentWatch Custom Market Surveillance

Custom Market Surveillance

DrugPatentWatch's Custom Market Surveillance provides you with a robust platform to monitor your business opportunities from every angle

Automated Reports

Stop Wasting Time & Money

How much time are you wasting on repetitive tasks?
DrugPatentWatch can take the load off of your team.

Don’t just take our word for it.
See why others use DrugPatentWatch and recommend it so highly.

❝ Information you don´t find anywhere else ❞

❝ I like best … the flexible subscription plans (by module, by month, by year, etc.) ❞

❝ My overall experience with DPW is very positive. The team is generally supportive and their features are growing over time. ❞

❝ Quick and easy to understand summaries, along with all the necessary links for further analysis. ❞

❝ Knowing when drugs are coming off patent and who to contract with has enabled us to stay ahead fo the curve and align ourselves with the proper vendors. ❞

❝ Drugpatentwatch is an excellent opportunity for LATAM companies to access information on expired and protected patents from the USA and worldwide in a friendly and easy manner. ❞

❝ This is a great service with lots of insightful information. ❞

❝ I like the interface, and how it updates with news ❞

❝ Found the results very comprehensive. The information told me who potential competitors are and what they are planning based on not only their NDAs and patents, but also references to clinical trials. ❞

Start working smarter.
See how companies in more than 70 countries are using DrugPatentWatch.

Global Biopharmaceutical Business Intelligence

Identify and evaluate commercial opportunities
Branded and generic drug pipeline forecasting
Anticipate future revenue events
Identify API and finished drug product suppliers

Try it Free

See Plans and Pricing

Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

Inform portfolio management decisions
Sector landscaping and due diligence
Track investigational drugs and explore new indications for existing drugs

Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

Study failed patent challenges to develop a better strategy
Collect competitive intelligence by examining contractual disputes
Track litigation to anticipate early generic entry

Try it Free

See Plans and Pricing

Drug Prices

Find and Evaluate Business Opportunities

Assess levels of generic competition
Use drug price ranges to evaluate price elasticity
Determine optimal prices before launch

Automated Reports

Automated Reports & Custom Dashboards

Do more with less staff
Take the load off your team
Automate processes and focus on growing your business

Try it Free

See Plans and Pricing

Track 505(b)(2) entrants

Monitor biosimilar and 505(b)(2) activity

Anticipate 505(b)(2) and biosimilar approvals
Track OTC-switches, new formulations, biosimilars, and other drug improvements
Strengthen new formulation patents by studying prior claims and litigation